Caribou Biosciences to Host KOL Event at ASH 2025 on Broadening Access to Second-Line Large B Cell Lymphoma Treatment with Vispa-cel

Caribou Biosciences will host an expert physician panel discussion at the 67th American Society of Hematology Annual Meeting and Exposition. The session will focus on how vispa-cel, an allogeneic anti-CD19 CAR-T cell therapy, can expand patient access for those with second-line large B cell lymphoma, including in the community setting. The event will be moderated by Tina Albertson, MD, PhD, and feature insights from leading physicians from community hospitals and academic centers.